The team led by researchers at Oregon Health & Science University (OHSU) think their 'one and done' model – which uses a cytomegalovirus (CMV) vector – could confer lifetime immunity against ...
The greater payload of the CMV vector allows delivery of larger or multiple genes, which will be important in the treatment of complex disorders,” said Church. BioViva’s early-stage CMV ...
The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...
Hosted on MSN1mon
Fortress doses first subject in Phase II CMV vaccine trialTriplex is a universal recombinant Modified Vaccinia Ankara viral vector vaccine. "Fortress doses first subject in Phase II CMV vaccine trial" was originally created and published by Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback